These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12123749)

  • 1. Hyperekplexia mutation of glycine receptors: decreased gating efficacy with altered binding thermodynamics.
    Maksay G; Bíró T; Laube B
    Biochem Pharmacol; 2002 Jul; 64(2):285-8. PubMed ID: 12123749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperekplexia mutation R271L of alpha1 glycine receptors potentiates allosteric interactions of nortropeines, propofol and glycine with [3H]strychnine binding.
    Maksay G; Bíró T; Laube B; Nemes P
    Neurochem Int; 2008 Jan; 52(1-2):235-40. PubMed ID: 17655979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propofol restores the function of "hyperekplexic" mutant glycine receptors in Xenopus oocytes and mice.
    O'Shea SM; Becker L; Weiher H; Betz H; Laube B
    J Neurosci; 2004 Mar; 24(9):2322-7. PubMed ID: 14999083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of glycine-gated chloride currents recorded in rat hippocampal slices.
    Chattipakorn SC; McMahon LL
    J Neurophysiol; 2002 Mar; 87(3):1515-25. PubMed ID: 11877523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc potentiation of the glycine receptor chloride channel is mediated by allosteric pathways.
    Lynch JW; Jacques P; Pierce KD; Schofield PR
    J Neurochem; 1998 Nov; 71(5):2159-68. PubMed ID: 9798943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycine receptor knock-in mice and hyperekplexia-like phenotypes: comparisons with the null mutant.
    Findlay GS; Phelan R; Roberts MT; Homanics GE; Bergeson SE; Lopreato GF; Mihic SJ; Blednov YA; Harris RA
    J Neurosci; 2003 Sep; 23(22):8051-9. PubMed ID: 12954867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of an arginine residue in the human glycine receptor transforms beta-alanine and taurine from agonists into competitive antagonists.
    Rajendra S; Lynch JW; Pierce KD; French CR; Barry PH; Schofield PR
    Neuron; 1995 Jan; 14(1):169-75. PubMed ID: 7826634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperekplexia mutations of the glycine receptor unmask the inhibitory subsite for beta-amino-acids.
    Laube B; Langosch D; Betz H; Schmieden V
    Neuroreport; 1995 Apr; 6(6):897-900. PubMed ID: 7542038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycine receptor α3 and α2 subunits mediate tonic and exogenous agonist-induced currents in forebrain.
    McCracken LM; Lowes DC; Salling MC; Carreau-Vollmer C; Odean NN; Blednov YA; Betz H; Harris RA; Harrison NL
    Proc Natl Acad Sci U S A; 2017 Aug; 114(34):E7179-E7186. PubMed ID: 28784756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric modulation of glycine receptors is more efficacious for partial rather than full agonists.
    Bíró T; Maksay G
    Neurochem Int; 2004 Jun; 44(7):521-7. PubMed ID: 15209420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a glycine receptor domain that controls the binding and gating mechanisms of the beta-amino acid agonist, taurine.
    Han NL; Haddrill JL; Lynch JW
    J Neurochem; 2001 Nov; 79(3):636-47. PubMed ID: 11701767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human glycine receptor beta subunit: primary structure, functional characterisation and chromosomal localisation of the human and murine genes.
    Handford CA; Lynch JW; Baker E; Webb GC; Ford JH; Sutherland GR; Schofield PR
    Brain Res Mol Brain Res; 1996 Jan; 35(1-2):211-9. PubMed ID: 8717357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional glycine receptor maturation in the absence of glycinergic input in dopaminergic neurones of the rat substantia nigra.
    Mangin JM; Guyon A; Eugène D; Paupardin-Tritsch D; Legendre P
    J Physiol; 2002 Aug; 542(Pt 3):685-97. PubMed ID: 12154171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermodynamics of agonist and antagonist interaction with the strychnine-sensitive glycine receptor.
    Ruiz-Gómez A; García-Calvo M; Vázquez J; Marvizón JC; Valdivieso F; Mayor F
    J Neurochem; 1989 Jun; 52(6):1775-80. PubMed ID: 2542450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The startle disease mutation Q266H, in the second transmembrane domain of the human glycine receptor, impairs channel gating.
    Moorhouse AJ; Jacques P; Barry PH; Schofield PR
    Mol Pharmacol; 1999 Feb; 55(2):386-95. PubMed ID: 9927632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine startle mutant Nmf11 affects the structural stability of the glycine receptor and increases deactivation.
    Wilkins ME; Caley A; Gielen MC; Harvey RJ; Smart TG
    J Physiol; 2016 Jul; 594(13):3589-607. PubMed ID: 27028707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mGluR5 antagonist MPEP elevates accumbal dopamine and glycine levels; interaction with strychnine-sensitive glycine receptors.
    Chau P; Söderpalm B; Ericson M
    Addict Biol; 2011 Oct; 16(4):591-9. PubMed ID: 21790901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel hyperekplexia-causing mutation in the pre-transmembrane segment 1 of the human glycine receptor alpha1 subunit reduces membrane expression and impairs gating by agonists.
    Castaldo P; Stefanoni P; Miceli F; Coppola G; Del Giudice EM; Bellini G; Pascotto A; Trudell JR; Harrison NL; Annunziato L; Taglialatela M
    J Biol Chem; 2004 Jun; 279(24):25598-604. PubMed ID: 15066993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of tonic glycinergic conductance in cerebellar granule cell signalling and the effect of gain-of-function mutation.
    McLaughlin C; Clements J; Oprişoreanu AM; Sylantyev S
    J Physiol; 2019 May; 597(9):2457-2481. PubMed ID: 30875431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential agonist sensitivity of glycine receptor alpha2 subunit splice variants.
    Miller PS; Harvey RJ; Smart TG
    Br J Pharmacol; 2004 Sep; 143(1):19-26. PubMed ID: 15302677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.